How could access to information overcome obstacles to HIV treatment in emerging markets?

Two-thirds of the world's population does not have ready access to the Internet. Fortunately, widespread efforts under way are changing this landscape, such as Facebook's Internet.org.

As an example, HIV patients face stigmas, poverty and other social barriers limiting their access to quality care. As people in emerging markets around the globe come online and experience newfound access to information, how can we use technology to help them understand diseases like HIV and why proper treatment is key to having a healthy future?

How can we leverage existing technology to increase "access" to more people in India?

Currently, the Mylan India commercial sales organization primarily focuses on marketing our products and services in metropolitan areas across India. However, approximately 68% of the Indian population lives in rural areas.

How can we leverage existing technology to create new models of communication between our sales organization, doctors, pharmacists and consumers, regardless of where they are located?

How can we better understand the state of "access" in the world?

With the enormous amount of data from a host of different organizations available on the Internet today, we now are able to gain new insights into the state of world health and understand patients like never before.

How can we leverage public datasets and application programming interfaces (API) to build insights and visualizations on which diseases are most burdensome to patients, hospitals and global economies?

How could we capture potential adverse events/adverse drug reaction notifications?

Prior to bringing a drug to market, pharmaceutical companies undertake extensive trials in accordance with requirements set forth by regulatory agencies.

After a product goes to market, pharmaceutical companies then track instances of Adverse Events and Adverse Drug Reactions for the drugs they manufacture and sell. These events frequently are posted on online via news feeds and social media.

How can we use technology to search for this information and identify the relevant company and their contact information?

How could we build a comprehensive Reference Listed Drug-Innovator Product Portal?

A generic drug is defined as a product that is comparable to a brand/reference listed drug product in dosage form, strength, quality and performance characteristics, and intended use.

Information on branded medicine often is reviewed or collected by searching regulatory websites.

How could we collate reference listed drug product information across various regulatory agency websites to generate reports, including the product name, marketing authorization holder, active ingredient, dosage form, strength and presentations/product information leaflets for all markets of interest?